These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21042264)

  • 1. Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.
    Jin J; Zhang JY; Guo N; Sheng H; Li L; Liang JC; Wang XL; Li Y; Liu MY; Wu XP; Yu L
    Molecules; 2010 Oct; 15(11):7750-62. PubMed ID: 21042264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
    Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
    J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis.
    Jin J; Zhang J; Guo N; Feng H; Li L; Liang J; Sun K; Wu X; Wang X; Liu M; Deng X; Yu L
    J Med Microbiol; 2011 Feb; 60(Pt 2):223-229. PubMed ID: 21051548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum.
    Ramón-García S; Martín C; Aínsa JA; De Rossi E
    J Antimicrob Chemother; 2006 Feb; 57(2):252-9. PubMed ID: 16373429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux pump effects on
    Valıyeva G; Durupınar B; Coban AY
    J Chemother; 2023 Nov; 35(7):601-609. PubMed ID: 36718107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
    Lechner D; Gibbons S; Bucar F
    J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
    Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
    BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems.
    Choudhuri BS; Sen S; Chakrabarti P
    Biochem Biophys Res Commun; 1999 Mar; 256(3):682-4. PubMed ID: 10080959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
    La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E
    Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in
    Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H
    Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a multidrug efflux pump in Mycobacterium smegmatis.
    Bansal A; Mallik D; Kar D; Ghosh AS
    FEMS Microbiol Lett; 2016 Jul; 363(13):. PubMed ID: 27190152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.
    Pasca MR; Guglierame P; De Rossi E; Zara F; Riccardi G
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4775-7. PubMed ID: 16251328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.
    Rodrigues L; Villellas C; Bailo R; Viveiros M; Aínsa JA
    Antimicrob Agents Chemother; 2013 Feb; 57(2):751-7. PubMed ID: 23165464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
    Rai D; Mehra S
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux pump effects on levofloxacin resistance in
    Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
    Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
    [No Abstract]   [Full Text] [Related]  

  • 16. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
    Solnier J; Martin L; Bhakta S; Bucar F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
    Piddock LJ; Williams KJ; Ricci V
    J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates.
    Li G; Zhang J; Li C; Guo Q; Jiang Y; Wei J; Qiu Y; Zhao X; Zhao LL; Lu J; Wan K
    J Antibiot (Tokyo); 2016 Mar; 69(3):173-5. PubMed ID: 26464012
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from
    Tran HT; Solnier J; Pferschy-Wenzig EM; Kunert O; Martin L; Bhakta S; Huynh L; Le TM; Bauer R; Bucar F
    Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32650510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.